The pathophysiology of SLE and ITP may be influenced by aberrant alterations in IL-18 and IL-18-binding protein (IL-18BP), according to several studies [61,62,63,64]. This evidence concerns the gene IL18BP and autoimmune thrombocytopenic purpura.